Axxima Pharmaceuticals is a pathogen-host signal transduction based drug discovery.

History:

The assets of Axxima Pharmaceuticals were acquired by GPC Biotech in 2005.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Europe

Research Focus:
Disease Therapeutics-Research Therapeutics-Development

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: